Differential Diagnosis of Myocardial Injury in the SARS-CoV-2 Era – Myocarditis Versus Acute Coronary Syndrome

1. Long B, Brady W, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38:1504-1507. doi: 10.1016/j.ajem.2020.04.048.10.1016/j.ajem.2020.04.048Search in Google Scholar

2. Paramasivam A, Priyadharsini JV, Raghunandhakumar S, et al. A novel COVID-19 and its effects on cardiovascular disease. Hypertens. 2020;43:729-730. doi: 10.1038/s41440-020-0461-x.10.1038/s41440-020-0461-xSearch in Google Scholar

3. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930-1936. doi: 10.1161/CIRCULATIONAHA.120.047164.10.1161/CIRCULATIONAHA.120.047164Search in Google Scholar

4. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069. doi: 10.1001/jama.2020.1585.10.1001/jama.2020.1585Search in Google Scholar

5. Zhou F, Ting Y, Ronghui D, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062. doi: 10.1016/S0140-6736(20)30566-3.10.1016/S0140-6736(20)30566-3Search in Google Scholar

6. Huang C, Wang Y, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5.10.1016/S0140-6736(20)30183-5Search in Google Scholar

7. Hu H, Ma F, Wei X, Fang Y, Hongde H. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;ehaa190. doi: 10.1093/eurheartj/ehaa190.10.1093/eurheartj/ehaa190718434832176300Search in Google Scholar

8. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-625. doi: 10.1111/j.1365-2362.2009.02153.x.10.1111/j.1365-2362.2009.02153.x716376619453650Search in Google Scholar

9. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-260. doi: 10.1038/s41569-020-0360-5.10.1038/s41569-020-0360-5709552432139904Search in Google Scholar

10. Shaobo S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41:2070-2079. doi: 10.1093/eurheartj/ehaa408.10.1093/eurheartj/ehaa408723910032391877Search in Google Scholar

11. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1-8. doi: 10.1001/jamacardio.2020.1017.10.1001/jamacardio.2020.1017710150632219356Search in Google Scholar

12. Nicin L, Abplanalp W, Mellentin H, et al. CoV-2 receptor ACE2 in human hearts. Eur Heart J. 2020;41:1807-1809. doi: 10.1093/eurheartj/ehaa410.10.1093/eurheartj/ehaa410723919132383758Search in Google Scholar

13. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810. doi: 10.1001/jamacardio.2020.0950.10.1001/jamacardio.2020.0950709784132211816Search in Google Scholar

14. Esfandrei M, McManus B. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3:127-155. doi: 10.1146/annurev.pathmechdis.3.121806.151534.10.1146/annurev.pathmechdis.3.121806.15153418039131Search in Google Scholar

15. Lee DW, Gardner R, Porter D, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188-195. doi: 10.1182/blood-2014-05-552729.10.1182/blood-2014-05-552729409368024876563Search in Google Scholar

16. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.e8. doi: 10.1016/j.cell.2020.02.052.10.1016/j.cell.2020.02.052710262732142651Search in Google Scholar

17. Driggin E, Madhavan M, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371. doi: 10.1016/j.jacc.2020.03.031.10.1016/j.jacc.2020.03.031719885632201335Search in Google Scholar

18. Caforio A, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636-2648. doi: 10.1093/eurheartj/eht210.10.1093/eurheartj/eht21023824828Search in Google Scholar

19. Kociol R, Cooper L, Fang J, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141:e69-e92. doi: 10.1161/CIR.0000000000000745.10.1161/CIR.000000000000074531902242Search in Google Scholar

20. Friedrich M, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475-1487. doi: 10.1016/j. jacc.2009.02.007.Search in Google Scholar

21. Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41:1861-1862. doi: 10.1093/eurheartj/ehaa286.10.1093/eurheartj/ehaa286718433932267502Search in Google Scholar

22. Schiavone M, Gobbi G, Biondi-Zoccai G, et al. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med. 2020;9:1683. doi: 10.3390/jcm9061683.10.3390/jcm9061683735653732498230Search in Google Scholar

23. Roffi M, Patrono C, Mueller C, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267-315. doi: 10.1093/eurheartj/ehv320.10.1093/eurheartj/ehv32026320110Search in Google Scholar

24. Thygesen K, Alpert J, Jaffe A, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:226. doi: 10.1093/eurheartj/ehy856.10.1093/eurheartj/ehy85630649367Search in Google Scholar

25. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197-2204. doi: 10.1093/eurheartj/ehq251.10.1093/eurheartj/ehq25120685679Search in Google Scholar

26. Scholz K, Maier S, Maier L, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39:1065-1074. doi: 10.1093/eurheartj/ehy004.10.1093/eurheartj/ehy004601891629452351Search in Google Scholar

27. Stefanini G, Azzolini E, Condorelli G. Critical organizational issues for cardiologists in the COVID-19 outbreak: A frontline experience from Milan, Italy. Circulation. 2020;141:1597-1599. doi: 10.1161/CIRCULATIONAHA.120.047070.10.1161/CIRCULATIONAHA.120.04707032207994Search in Google Scholar

28. Mahmud E, Dauerman H, Welt F, et al. Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. 2020;S0735-1097(20)35026-9. doi: 10.1016/j. jacc.2020.04.039.Search in Google Scholar

29. Leurent G, Langella B, Fougerou C, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis. 2011;104:161-170. doi: 10.1016/j.acvd.2011.01.005.10.1016/j.acvd.2011.01.00521497305Search in Google Scholar

30. Clerkin K, Fried J, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141:1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941.10.1161/CIRCULATIONAHA.120.04694132200663Search in Google Scholar

31. Cheng R, Leedy D. COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart. 2020;106:1122-1124. doi: 10.1136/heartjnl-2020-317025.10.1136/heartjnl-2020-317025721109632354799Search in Google Scholar

32. Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Infection. 2020;1-5. doi: 10.1007/s15010-020-01424-5.10.1007/s15010-020-01424-5714607232277408Search in Google Scholar